Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
InMed Pharmaceuticals Inc. (INM) is identified as the issuer for Schedule 13G ownership disclosures by Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., Deep Track Special Opportunities Fund, LP, and David Kroin. Deep Track Capital and Kroin each reported beneficial ownership of 2,977,478 shares, or 5.64%; the Master Fund reported 2,214,135 shares (4.19%), and the Special Opportunities Fund reported 763,343 shares (1.45%). Each reported shared voting and dispositive power over its stated amount. The ownership amounts were reported as of November 13, 2026.
Key Figures
Beneficial ownership — Deep Track Capital, LP:2,977,478 shares; 5.64%Beneficial ownership — David Kroin:2,977,478 shares; 5.64%Beneficial ownership — Deep Track Biotechnology Master Fund, Ltd.:2,214,135 shares; 4.19%+2 more
5 metrics
Beneficial ownership — Deep Track Capital, LP2,977,478 shares; 5.64%Reported as of November 13, 2026; shared voting and dispositive power.
Beneficial ownership — David Kroin2,977,478 shares; 5.64%Reported as of November 13, 2026; shared voting and dispositive power.
Beneficial ownership — Deep Track Biotechnology Master Fund, Ltd.2,214,135 shares; 4.19%Reported as of November 13, 2026; shared voting and dispositive power.
Beneficial ownership — Deep Track Special Opportunities Fund, LP763,343 shares; 1.45%Reported as of November 13, 2026; shared voting and dispositive power.
Common shares outstanding52,813,914 sharesAs of November 10, 2026; used to calculate the reported ownership percentages.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Powerregulatory
"Shared Voting Power 2,977,478"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 2,977,478"
Rule 13d-1(k)regulatory
"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many INM shares did Deep Track Capital report beneficially owning?
Deep Track Capital, LP reported beneficial ownership of 2,977,478 shares, or 5.64%. David Kroin reported the same amount; Deep Track Biotechnology Master Fund, Ltd. reported 2,214,135 shares (4.19%), and Deep Track Special Opportunities Fund, LP reported 763,343 shares (1.45%).
What share count was used to calculate the INM ownership percentages?
The ownership percentages were based on 52,813,914 common shares outstanding as of November 10, 2026, as reported by the issuer in an 8-K filed that day.
(i) Delaware
(ii) Cayman Islands
(iii) United States
(iv) Delaware
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP Number(s):
587157108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
2,977,478
(b)
Percent of class:
5.64%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
2,977,478
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
2,977,478
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Deep Track Capital, LP is the relevant entity for which David Kroin may be considered a control person.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Deep Track Capital, LP
Signature:
/s/ David Kroin
Name/Title:
David Kroin, Managing Member of the General Partner of the Investment Adviser
Date:
11/13/2026
Deep Track Biotechnology Master Fund, Ltd.
Signature:
/s/ David Kroin
Name/Title:
David Kroin, Director
Date:
11/13/2026
David Kroin
Signature:
/s/ David Kroin
Name/Title:
David Kroin
Date:
11/13/2026
Deep Track Special Opportunities Fund, LP.
Signature:
/s/ David Kroin
Name/Title:
David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP
Date:
11/13/2026
Exhibit Information
Item 4: Information with respect to the Reporting Persons' ownership of the Common Shares as of November 13, 2026, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person.
The amount beneficially owned by each Reporting Person is determined using 52,813,914 Common Shares outstanding as of November 10, 2026, as reported by the issuer on its 8-K filed with the SEC on November 10, 2026.
JOINT FILING STATEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
Dated: November 13, 2026
Deep Track Capital, LP
By: /s/ David Kroin
David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd.
By: /s/ David Kroin
David Kroin, Director
David Kroin
By: /s/ David Kroin
David Kroin
Deep Track Special Opportunities Fund, LP.
By: /s/ David Kroin
David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP